75 results
Page 2 of 4
8-K
EX-99.1
9qfd mwva3e
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am
8-K
EX-99.1
5yw4u4t5d7tkhh4d0
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
8-K
EX-10.12
9fzirmhib4ky
17 Aug 09
Other Events
12:00am
8-K
EX-10.14
8qkw8
17 Aug 09
Other Events
12:00am
8-K
EX-99.1
vurjg64dkibgw bq
28 Apr 09
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am
424B5
50pyept
17 Nov 06
Prospectus supplement for primary offering
12:00am